Association Between HLA Polymorphisms and Non-Alcoholic Fatty Liver Disease in Patients with Rheumatoid Arthritis: An Observational Study
Diseases · 22.03.2026 · 14 (3) · 113
DOI: 10.3390/diseases14030113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases, online erschienen am 22.03.2026. Verfasst von Tatjana Zekić und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: This observational study investigated associations between human leukocyte antigen (HLA) polymorphisms and imaging-defined hepatic steatosis (non-alcoholic fatty liver disease—NAFLD) and liver fibrosis in patients with rheumatoid arthritis (RA).
Methods
Steatosis was assessed by transient elastography (FibroScan) and defined as controlled attenuation parameter (CAP) ≥ 275 dB/m; fibrosis was defined as liver stiffness measurement ≥ 8 kPa. We tested 11 frequent HLA alleles (HLA-A*02, HLA-B*07, HLA-B*08, HLA-B*27, HLA-B*35, HLA-B*44, HLA-B*51, HLA-DRB1*11, HLA-DRB1*14, HLA-DRB1*15, and HLA-DRB1*16). Associations were evaluated using multivariable logistic regression (individual and omnibus models) adjusted for age, body mass index (BMI), triglycerides, and glucose.
Results
A total of 176 patients with rheumatoid arthritis were enrolled. NAFLD/steatosis was present in 35.2% of patients (n = 62), and fibrosis in 10.8% (n = 19). No HLA allele was significantly associated with steatosis or fibrosis after correction for multiple testing. BMI and triglycerides were independently associated with steatosis (BMI OR 1.22, 95% CI 1.12–1.34; triglycerides OR 1.48, 95% CI 1.04–2.18). For fibrosis, HLA-DRB1*15 showed the strongest trend-level association (OR ~2.6–2.9) but did not remain significant after correcting for multiple testing.
Conclusions
In this RA cohort, metabolic factors (particularly BMI and triglycerides) were the dominant predictors of CAP-defined steatosis. No robust association between the tested HLA markers and steatosis or fibrosis was identified. Trend-level signals—most notably HLA-DRB1*15 for fibrosis—should be considered hypothesis-generating and warrant replication in larger, adequately powered cohorts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia.
- Clinical Hospital Center Rijeka, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
- Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
ORCID-Profile: Nataša Katalinić
Zitieren
APA
Zekić, T., Katalinić, N., Blažić, F., Starčević Čizmarević, N., & Čubranić, A. (2026). Association Between HLA Polymorphisms and Non-Alcoholic Fatty Liver Disease in Patients with Rheumatoid Arthritis: An Observational Study. Diseases, 14(3), 113. https://doi.org/10.3390/diseases14030113
Vancouver
Zekić T, Katalinić N, Blažić F, Starčević Čizmarević N, Čubranić A. Association Between HLA Polymorphisms and Non-Alcoholic Fatty Liver Disease in Patients with Rheumatoid Arthritis: An Observational Study. Diseases. 2026;14(3):113. doi:10.3390/diseases14030113
BibTeX
@article{Zeki2026,
author = {Zekić, Tatjana and Katalinić, Nataša and Blažić, Filip and Starčević Čizmarević, Nada and Čubranić, Aleksandar},
title = {Association Between HLA Polymorphisms and Non-Alcoholic Fatty Liver Disease in Patients with Rheumatoid Arthritis: An Observational Study},
journal = {Diseases},
year = {2026},
volume = {14},
number = {3},
pages = {113},
doi = {10.3390/diseases14030113}
}
EUVIMED